Vaneja Velenik

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +9

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Vaneja Velenik, Janja Ocvirk, Maja Marolt Mušič et al. · Radiation Oncology · 2011 · 87 citations · Full text

Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer

Peter Grimminger, Peter V. Danenberg, Kathrin Dellas et al. · Clinical Cancer Research · 2011 · 57 citations · Full text

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

Vaneja Velenik, Janja Ocvirk, Irena Oblak et al. · European Journal of Surgical Oncology · 2009 · 53 citations · Full text

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

Siwen Hu‐Lieskovan, Daniel Vallböhmer, Wu Zhang et al. · Clinical Cancer Research · 2011 · 49 citations · Full text